| Name | L-Alanyl-L-serylglycyl-L-prolyl-L-leucylglycyl-L-threonyl-L-leucyl-L-alanyl-L-α-glutamyl-L-α-glutamyl-L-leucyl-L-seryl-L-seryl-L-tyrosyl-L-seryl-L-arginyl-L-arginyl-L-lysylglycylglycyl-L-phenylalanyl-L-seryl-L-phenylalanyl-L-arginyl-L-phenylalaninamide |
|---|---|
| Synonyms |
L-Alanyl-L-serylglycyl-L-prolyl-L-leucylglycyl-L-threonyl-L-leucyl-L-alanyl-L-α-glutamyl-L-α-glutamyl-L-leucyl-L-seryl-L-seryl-L-tyrosyl-L-seryl-L-arginyl-L-arginyl-L-lysylglycylglycyl-L-pheny lalanyl-L-seryl-L-phenylalanyl-L-arginyl-L-phenylalaninamide
Orphan GPCR SP9155 Agonist P550 (mouse) trifluoroacetate salt |
| Description | Orphan GPCR SP9155 agonist P550 (mouse, rat) (26RFa (mouse, rat)), a member of the RFamide peptide family with orexigenic effect, is the cognate ligand of the mouse orphan receptor GPR103, also designated SP9155 or AQ27[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | 26RFa is a key neuropeptide in the regulation of energy metabolism[2]. |
| In Vivo | 26RFa dose-dependently reduces glucose-induced insulin release, inhibits the insulin responses to both arginine and exendin-4 and did not affect glucagon output in rat pancreas[3]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C126H195N37O37 |
| Molecular Weight | 2820.122 |
| Exact Mass | 2818.451416 |
| LogP | -5.87 |
| Index of Refraction | 1.664 |